Skip to main content
Intermediate Technical IVT

SLNB

Also written as: SLNB — sentinel lymph node biopsy

Acronym for sentinel lymph node biopsy, a staging procedure to assess lymphatic spread in cancer patients.

Full Definition

SLNB (sentinel lymph node biopsy) is a minimally invasive surgical technique used to determine whether cancer has spread to nearby lymph nodes. The procedure involves identifying and removing the first lymph node or nodes that cancer cells would likely reach from a primary tumor site. A radioactive tracer and/or blue dye is injected near the tumor to map the lymphatic drainage pathway. This technique is widely used in breast cancer, melanoma, and other solid tumors to guide treatment decisions while minimizing surgical morbidity compared to complete lymph node dissection.

Usage

Usage note: Always spell out on first use in patient documents; commonly abbreviated in clinical notes.

In Context

  • "The pathology report confirmed negative SLNB results, allowing the patient to avoid axillary lymph node dissection." — Clinical documentation
  • "SLNB has become the standard of care for clinically node-negative breast cancer patients." — Treatment guideline

Also known as

sentinel node biopsy

Contrasted with

complete lymph node dissection

Don't confuse with

ALND lymphadenectomy

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON